BUSINESS/FINANCE NEWS
Setup News Ticker
   BUSINESS/FINANCE NEWS
Searching for 'trade stocks'. (Return)

MarketWatchNov 15, 2019
Market Snapshot: U.S. stocks climb to fresh records on revived hope for U.S. - China trade deal
U.S. stocks closed at fresh record highs on Friday on revived hopes for a U.S. - China trade deal despite mixed economic data.

RELATED ARTICLES
Dow passes 28,000 as trade hopes lift US stocks to record highs (FT.com - Financial Markets)
Trade deal hopes, surging health stocks power Wall Street to highs (Reuters Business)

MarketWatch MarketPulseNov 15, 2019
Health stocks post best day in 10 months as Trump announces transparency rules
A popular exchange-traded fund that tracks the health-care sector saw its best daily return in 10 months on Friday after the Trump administration proposed new rules aimed at making health-care prices more transparent. The SPDR Health Care Select Sector ETF posted a 2.1%, marking its best day since Jan. 4, when it rose 2.98%, according to FactSet data. The Trump administration proposed a rule that would require health insurers to disclose estimated out-of-pocket costs, including negotiated rates, to patients in advance of a procedure or office visit. It also finalized a rule requiring hospitals to make transparent the prices they charge patients starting in 2021. It's possible that the stocks gained on doubts on how the rules would be enforced. "While the Trump administration's new hospital price transparency requirement is quite sweeping, the enforcement of it is quite weak - a maximum fine of $300 per day," Kaiser Family Foundation executive Larry Levitt wrote on Twitter. Shares of UnitedHealth Group Inc. , which is the largest health insurer in the U.S., and Anthem Inc. each rose roughly 5%. Shares of Tenet Healthcare Corp. and HCA Healthcare Inc. , both large hospital operators, were up at least 2%. The S&P 500 is up 24.4% year-to-date.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.



MarketWatch MarketPulseNov 15, 2019
Major stock indexes close at new highs on fresh trade optimism and retail sales beat
U.S. stocks swept to fresh records as investors turned more bullish on a trade deal with China and focused on rosy consumer data. The Dow Jones Industrial Average closed about 222 points, 0.8%, higher, just above 28,000. The S&P 500 jumped 24 points, 0.8%, to close at about 3,120. The Nasdaq was about 62 points, 0.7%, higher at the close, at 8,541. Shares of J.C. Penney Co. Inc. jumped after beating earnings expectations for the recent quarter.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.



CNBC FinanceNov 15, 2019
After Dow tops 28,000, the next 1,000 points will be determined by trade talks
Stocks bounced on trade headlines on Friday, but the market could stall out in the week ahead if there is no real progress toward a deal.

Reuters Company NewsNov 15, 2019
US STOCKS-Trade deal hopes, surging health stocks power Wall St to highs
* U.S., China getting close to trade deal-White House adviser

Google Market NewsNov 15, 2019
Dow breaks 28,000 with big boost from one company - Fox Business
Dow breaks 28,000 with big boost from one company  Fox BusinessDow hits 28,000 for the first time  CNNDOW 28,000!  BreitbartDow tops 28,000 as US, China trade deal comes together  Fox BusinessStocks- S&P 500 Soars to 6th Weekly Gain By  Investing.com

Reuters BusinessNov 15, 2019
U.S.-China trade hopes revive stocks, crude rises
Crude prices and global equities markets rose on Friday, with the major U.S. indexes setting record highs, on renewed hopes that the United States and China will reach a deal to de-escalate a 16-month trade war that has crimped global growth.

RELATED ARTICLES
GLOBAL MARKETS-U.S.-China trade hopes revive stocks, crude rises (Reuters Company News)

MarketWatch MarketPulseNov 15, 2019
FTC makes Celgene's Otezla divestiture official condition for Bristol-Myers acquisition
Celgene Corp. is required to divest its most popular psoriasis treatment in order to be acquired by Bristol-Myers Squibb Co. , the Federal Trade Commission announced Friday. For Bristol-Myers to close on its $74 billion acquisition, Celgene will have to sell its drug Otezla for $13.4 billion to Amgen Inc. , the FTC said. "The Commission has ordered BMS to divest Otezla to preserve BMS's incentive to continue developing its own oral product for treating moderate-to-severe psoriasis," said FTC Chairman Joseph Simons in a statement. "The antitrust laws protect not only competition today, but competition in the future, especially when it comes to the development of new treatments for chronic conditions." The companies already anticipated the FTC's concerns and agreed to the deal back in August.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.


TRENDING TAGS
TrumpCourt post CNN Tax Subpoena
Stockstrade hopes deal Wall record
tradedeal hopes stocks Wall record
FundHedge close bond Stock latest
&Johnson Judge Opioid Reduces million
UPDATEJohnson Google drug tightens bans
Stocktrade hopes Market Cannabis deal
Johnson& judge opioid million reduces
TaxTrump Subpoena Court Supreme returns
Marketstock trade stocks Dow MarketWatch

NEWS SOURCES
Top News (Business News)
Accounting Today
AdWeek News
Banking Business Review
Barron's This Week Magazine
Barron's Up and Down Wall Street Daily
Brad Ideas
Chicago Tribune Business News
CNBC Business
CNBC Economy
CNBC Finance
CNN/Money
CNN/Money Real Estate News
Dismal.com: Analysis
Dismal.com: Indicators
Enterprise Application News
Entrepreneur.com
Forbes Headlines
Forbes Social Media News
FT.com - China, Economy & Trade
FT.com - Financial Markets
FT.com - Hedge Funds
FT.com - Telecoms
FT.com - US
Google Business News
Google Market News
HBS Working Knowledge
Inc.com
INSEAD Knowledge
International Tax Review
Kiplinger
Knowledge@Wharton
L.S. Starrett News
MarketWatch
MarketWatch Breaking News
MarketWatch MarketPulse
McKinsey Quarterly
MSNBC.com: Business
Nielsen Trends
NonProfit Times
NPR Topics: Business
NYTimes Business
OpinionJournal.com
Private Equity Breaking News
Reuters Business
Reuters Company News
Reuters Money
SEC.gov Updates: News Digest
SHRM HR News
Tax Policy News
The Economist International News
The Motley Fool
USA Today Money
Wall Street Journal US Business
Wall Street Transcript
Washington Post Business
WSJ Asia
WSJ Europe
WSJ MoneyBeat
WSJ Opinion
WSJ US News
WSJ World Markets
Yahoo Business
  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • 617 482 1200
    617 299 8649 (fax)
  • Contact
  • As an Amazon Associate
    CEOExpress earns from
    qualifying purchases.

©1999-2019 CEOExpress Company LLC